Overview

Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension

Status:
Completed

Trial end date:
2009-08-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to evaluate the BP-lowering efficacy of the combination of aliskiren and amlodipine, as initial therapy, compared to amlodipine monotherapy in African American patients with Stage II hypertension.

Phase:

Phase 4

Details

Lead Sponsor:

Novartis

Treatments:

Amlodipine